Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Fleming SM, Mulligan CK, Richter F, Mortazavi F, Lemesre V, Frias C, Zhu C, Stewart A, Gozes I, Morimoto B, Chesselet MF.

Mol Cell Neurosci. 2011 Mar;46(3):597-606. doi: 10.1016/j.mcn.2010.12.011. Epub 2010 Dec 27.

2.

α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.

Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A.

Brain Struct Funct. 2014 Sep;219(5):1513-26. doi: 10.1007/s00429-013-0651-2. Epub 2013 Oct 18. Review.

PMID:
24135772
3.

Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?

Olanow CW, Brundin P.

Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Review.

PMID:
23390095
4.

A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.

Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR.

Neurotherapeutics. 2012 Apr;9(2):297-314. doi: 10.1007/s13311-012-0104-2. Review.

5.

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Ferrer I, Martinez A, Blanco R, Dalfó E, Carmona M.

J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Epub 2010 Sep 23. Review.

PMID:
20862500
6.
7.

Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?

Fujita M, Sekigawa A, Sekiyama K, Sugama S, Hashimoto M.

J Neurol. 2009 Aug;256 Suppl 3:286-92. doi: 10.1007/s00415-009-5246-8. Review.

PMID:
19711118
8.

Alpha-synuclein-based models of Parkinson's disease.

Dehay B, Fernagut PO.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):371-8. doi: 10.1016/j.neurol.2016.04.003. Epub 2016 May 2. Review.

PMID:
27158042
9.

Genetically engineered mouse models of Parkinson's disease.

Crabtree DM, Zhang J.

Brain Res Bull. 2012 May 1;88(1):13-32. doi: 10.1016/j.brainresbull.2011.07.019. Epub 2011 Aug 3. Review.

10.

Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.

Klingelhoefer L, Reichmann H.

Nat Rev Neurol. 2015 Nov;11(11):625-36. doi: 10.1038/nrneurol.2015.197. Epub 2015 Oct 27. Review.

PMID:
26503923
11.

Mechanism of Anti-α-Synuclein Immunotherapy.

Lee JS, Lee SJ.

J Mov Disord. 2016 Jan;9(1):14-9. doi: 10.14802/jmd.15059. Epub 2016 Jan 25. Review.

Supplemental Content

Support Center